DaVita
DVA
#1982
Rank
C$14.25 B
Marketcap
C$213.22
Share price
2.46%
Change (1 day)
0.60%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): C$14.03

According to DaVita's latest financial reports the company's current EPS (TTM) is C$13.81. In 2024 the company made an earnings per share (EPS) of C$15.05 an increase over its 2023 EPS that were of C$10.38.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$14.03-6.79%
2024C$15.0544.94%
2023C$10.3827.26%
2022C$8.16-35.56%
2021C$12.6644.1%
2020C$8.7919.7%
2019C$7.34540.48%
2018C$1.15-76.07%
2017C$4.79-19.31%
2016C$5.93242.52%
2015C$1.73-62.87%
2014C$4.6713.43%
2013C$4.118.45%
2012C$3.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
C$29.13 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$13.98 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
C$20.05 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.59-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA